Guglielmino, Valeria
Vitali, Francesca
Romano, Angela
Primiano, Guido
Sciarrone, Maria Ausilia
Luigetti, Marco https://orcid.org/0000-0001-7539-505X
Article History
Received: 13 November 2024
Accepted: 10 December 2024
First Online: 3 January 2025
Declarations
:
: Marco Luigetti is an Editorial Board member of Neurology and Therapy. Marco Luigetti was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Marco Luigetti received financial grants (honoraria and speaking) from Ackea, Alnylam, AstraZeneca, Sobi, and Pfzer, and travel grants from Ackea, Alnylam, Sobi, Pfzer, Kedrion, and Grifols. Angela Romano received financial grants (honoraria and speaking) from Akcea, and travel grants from Akcea, Alnylam, Pfzer, and Csl Behring. Guido Primiano received financial grants (honoraria and speaking) from Sanofi. The other authors have no conficts of interest to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.